Craig Bissinger, MD
Obstetrics & Gynecology · Parsippany, NJNPI 1083607865
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,950 of the $9,637 with a category attached, or 92.9%. Celularity Inc. accounts for 93.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $2,968 and has fallen 99.2% since, to $25 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $125.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$9K
- Astellas Pharma US Inc$99
- Hologic Sales And Service, LLC$88
- AbbVie$87
- Bayer$61
- Therapeuticsmd, Inc.$55
- plus $242 from 9 others
What the payments were for
- Speaking & faculty fees$8,95093%
- Food & beverage$6527%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 37 | $9,006 |
| Astellas Pharma US Inc | 5 | $99 |
| Hologic Sales And Service, LLC | 1 | $88 |
| AbbVie(2 entities) | 6 | $87 |
| Bayer | 3 | $61 |
| Therapeuticsmd, Inc. | 4 | $55 |
| Mayne Pharma Commercial LLC | 8 | $48 |
| AMAG Pharmaceuticals, Inc. | 2 | $35 |
| Avion Pharmaceuticals | 2 | $28 |
| Pfizer | 2 | $28 |
| Vertical Pharmaceuticals, LLC | 2 | $26 |
| Exact Sciences | 1 | $25 |
| Alydia Health | 2 | $24 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $14 |
How this compares
$9,637 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 122 | $9,983 |
| Raloxifene Hcl | 22 | $1,018 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Parsippany
- Vanessa ValarezoParsippany$9K
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.